The VELO system supports multiplex testing for Influenza A, Influenza B, and COVID-19, producing PCR results in six to ten minutes
The trial, which compared Retevmo to placebo, met its primary endpoint with a “highly statistically significant and clinically meaningful improvement” in investigator-assessed EFS for patients with stage II–IIIA disease
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
This Orphan Drug Designation from the USFDA underlines the urgent medical need to develop a therapy for sickle cell disease
Hologic has been at the forefront of cervical cancer screening for decades
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
N17350 is the company’s first-in-class tumor-directed therapeutic, designed to harness the ELANE pathway
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
